Polyendocrine Syndromes & Psychiatric Presentation in Patients

This is why a precision based approach to psychiatry is necessary and not the antiquated and discredited system known as psychogenics, which far more resemble a belief system than any modern scientific evidence based medicine system. 

The psychogenic ‘symptom’ based approach to diagnosis is more a relic of the early 20^th century than an evidence based medicine model and in the main health trusts still relying on this are likely lazy and dogmatic and have failed to keep up with neurological research and appropriate training of staff.  Apart from the obvious distress this causes to patients and their loved ones it represents a retrograde attitude to advancing psychiatric and neurological models.  Patents often spend years misdiagnosed and consequently incorrectly treated and more often than not detained in the forensic legal system that also sustains this intellectual bankruptcy in the medical professions. 

The underlying motivation of psychogenic psychiatry is isolation, deprivation of liberty and containment of what is often seem as more of a legal problem than one involving innocent victims of a medical pathology. 

There are several plausible and increasingly studied links between polyendocrine disorders and dysfunctional signaling in the mesolimbic system, particularly involving dopamine, stress hormones, immune signaling, and metabolic hormones. But the relationship is complex and usually indirect rather than a single unified disease mechanism.

The mesolimbic system (especially the VTA → nucleus accumbens dopamine pathway) regulates motivation, reward salience, reinforcement learning, mood, and aspects of energy regulation. Dysregulation in this circuit is implicated in depression, addiction, anhedonia, compulsive behaviours, schizophrenia-spectrum symptoms, and altered motivational states. 

Several endocrine systems feed directly into this circuitry:

1.     Cortisol / HPA axis

2.     Thyroid hormones

3.     Insulin and leptin

4.     Sex steroids

5.     Inflammatory cytokines

6.     Orexin and ghrelin signaling

7.     Prolactin-dopamine feedback loops

So when multiple endocrine systems become dysregulated simultaneously, as in polyendocrine syndromes mesolimbic signaling can adversely be affected.

A few examples of Autoimmune polyendocrine syndromes includes conditions like autoimmune polyendocrine syndrome (APS) often involve chronic inflammation, adrenal dysfunction, thyroid disease, diabetes, or gonadal hormone abnormalities. Cytokines and glucocorticoid instability can alter dopamine neuron firing and reward processing. Chronic inflammatory states are increasingly associated with reduced dopaminergic motivation signaling and anhedonia. 

Thyroid dysfunction.  Hypothyroidism can blunt dopaminergic tone and produce apathy, reduced motivation, depression and cognitive slowing

Hyperthyroidism can produce anxiety, agitation, reward/salience dysregulation and sometimes psychosis-like symptoms

These effects likely involve mesocorticolimbic dopamine modulation. The mesolimbic pathway is highly sensitive to glucocorticoids. Chronic excess cortisol can alter reward salience and stress responsivity, while adrenal insufficiency can impair motivation and emotional regulation. Stress-hormone modulation of VTA dopamine neurons is well established. 

Diabetes and insulin resistance influences. Insulin receptors are expressed in mesolimbic dopamine regions. Impaired insulin signaling can alter reward valuation, food motivation, impulsivity, and dopaminergic transmission. This is one reason metabolic disease and compulsive eating/addiction phenotypes overlap neurobiologically. 

Prolactin and dopamine.  There is a direct endocrine-dopamine loop. Dopamine inhibits prolactin release through D2 receptor signaling. Disorders involving prolactin, pituitary dysfunction, or dopamine blockade can therefore affect motivation, libido, affect, and reward processing. 

There is also an emerging idea that some syndromes that appear “psychiatric,” “metabolic,” and “endocrine” at the same time may involve shared network dysfunction between hypothalamic regulation, immune signaling, salience/reward circuitry and autonomic regulation

That overlap is especially discussed in chronic stress disorders, obesity/metabolic syndrome, inflammatory illnesses, chronic pain syndromes and some neuroimmune conditions

A mesolimbic abnormality would not usually be considered the primary cause of a polyendocrine disorder in mainstream medicine.  More commonly endocrine dysfunction alters mesolimbic signaling, or both are affected by a third process (autoimmune, inflammatory, genetic, developmental, or stress-related).

So the association is biologically credible and supported by growing evidence, but it is not yet a fully unified or clinically standardized framework.